This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References and Suggested Reading
Abrams MJ, Davison A, Jones AG, et al. Synthesis and characterization of hexakis (alkylisocyanide) and hexakis (arylisocyanide complexes of Technetium (I). Inorg Chem. 1983; 22:2798.
Callahan RJ, Froelich JW, McKusick KA, et al. A modified method for the in vivo labeling of red blood cells with Tc-99m: concise communication. J Nucl Med. 1982; 23:315.
Dewanjee MK. The chemistry of 99mTc-labeled radiopharmaceuticals. Semin Nucl Med. 1990; 20:5.
Eckelman WC, Stiegman J, Paik CH. Radiopharmaceutical chemistry. In: Harpert J, Eckelman WC, Neumann RD, eds, Nuclear Medicine: Diagnosis and Therapy. New York: Thieme Medical; 1996:217.
Edwards DS, Cheeseman EH, Watson MW, et al. Synthesis and characterization of technetium and rhenium complexes of N, N’-1, 2-diethylenediylbis-L-cysteine. Neurolites and its metabolites. In: Nicolini M, Bandoli G, Mazzi U, eds. Technetium and Rhenium in Chemistry and Nuclear Medicine. Verona, Italy: Cortina International; 1990; 433.
Fritzberg AR, Kasina S, Eshima D, et al. Synthesis and biological evaluation of technetium-99m MAG3 as hippuran replacement. J Nucl Med. 1986; 27:11.
Hamacher K, Coenen HH, Stocklin G. Efficient stereospecific synthesis of NCA 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution.J Nucl Med. 1986; 27:235.
Hnatowich DJ. Recent developments in the radiolabeling of antibodies with iodine, indium and technetium. Semin Nucl Med. 1990; 20:80.
Kabalka GW, Lambrecht RM, Fowler JS, et al. Synthesis of 15O-labelled butanol via organoborane chemistry. Appl Radiat Isot. 1985; 36:853.
Kelly JD, Forster AM, Higley B, et al. Technetium-99m-tetrofosmin as a new radiopharmaceutical for myocardial perfusion imaging. J Nucl Med. 1993; 34:222.
Kōhler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975; 256:495.
Loberg MD, Cooper M, Harvey E, et al. Development of new radiopharmaceuticals based on N-substitution of iminodiacetic acid. J Nucl Med. 1976; 17:633.
Luxen A, Bida GT, Phelps ME, et al. Synthesis of enantiomerically pure D and L 6-[F-18] fluorodopa and in vivo metabolites via regioselective fluorodemercuration. J Nucl Med. 1987; 28:624.
Machulla HJ, Blocher A, Kuntzsch M, et al. Simplified labeling approach for synthesizing 3’-dioxy-3’-[18F] fluorothymidine ([18F] FLT). J Radioanal Nucl Chem. 2000; 243:843.
Meyer GJ, Ostercholz A, Hundeshagen H. 15O-Water constant infusion system for clinical routine application. J Label Comp Radiopharm. 1986; 23:1209.
Nunn AD. Radiopharmaceutical for imaging myocardial perfusion. Semin Nucl Med. 1990; 20:111.
Package inserts of various kits available from commercial suppliers.
Peters AM, Danpure HJ, Osman S, et al. Clinical experience with 99mTc-hexamethyl propylene amine oxime for labeling leukocytes and imaging inflammation. Lancet. 1986; 2:946.
Sodd VJ, Allen DR, Hoagland DR, et al., eds. Radiopharmaceuticals II. New York: Society of Nuclear Medicine; 1979.
ten Berge RJM, Natarajan AT, Hardenman MR, et al. Labeling with indium-111 has detrimental effects on human lymphocytes. J Nucl Med. 1983; 24:615.
Thakur ML, Coleman RE, Welch MJ. Indium-111-labeled leukocytes for the localization of abscesses: preparation, analysis, tissue distribution and comparison with gallium-67 citrate in dogs. J Lab Clin Med. 1977; 82:217.
Troutner DR, Volkert WA, Hoffman TJ, et al. A neutral lipophilic complex of Tc-99m with a multidentate amine oxime. Int J Appl Radiat Isot. 1984; 35:467.
U.S. Pharmacopeia 26 & National Formulary 21. United States Pharmacopeial Convention, Rockville, MD; 2003.
Vanzelto G, Fagret D, Pasqualini R, et al. Biodistribution, dosimetry and safety of myocardial perfusion agent 99mTc-N-NOET in healthy volunteers. J Nucl Med. 2000; 41:141.
Welch MJ, ed. Radiopharmaceuticals and Other compounds Labelled with Short-Lived Radionuclides. New York: Pergamon Press; 1977.
Zuckier LS, Rodriguez LD, Scharff MD. Immunologic and pharmacologic concepts of monoclonal antibodies. Semin Nucl Med. 1990; 20:166.
Rights and permissions
Copyright information
© 2004 Springer-Verlag New York, Inc.
About this chapter
Cite this chapter
(2004). Characteristics of Specific Radiopharmaceuticals. In: Fundamentals of Nuclear Pharmacy. Springer, New York, NY. https://doi.org/10.1007/0-387-21702-9_7
Download citation
DOI: https://doi.org/10.1007/0-387-21702-9_7
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-40360-1
Online ISBN: 978-0-387-21702-4
eBook Packages: Springer Book Archive